---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
webUrl: "https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

secured: "UJnKTFqA2bqh2n9T06NkaheDXUlnVPZm4Sp7ylchg/bumwB8aTByzWA6AiYpHP6fkEpF2brN880+xsx5/Fu8vRqzGj1jbxLKBxxpYp3dO+lXQCujraNXRdrCQm6BgYtCSbUbjelI+KFq5fsqrbcWPyfCYsBj811RuI0dAW7SnyLUPNzGjJf+1jUDWb5utBfyrFTKpnaBt5Me3qe6p6liYXiXPPAoljLYxQf+vLEkjbB0uCXih9aW5krm9X3xPqk2jVzMZnKl/gejEsP/pDjUUeQnJJ7LIsv4Hmjj/eIYfIO6KCafqrqOFCXO/Y53xUSC;viTd3zX4r4/klns3alYJnA=="
---

